Clinical Trial Update: Improving Neuroprotective Strategy for Ischemic Stroke With Sufficient Recanalization After Thrombectomy by Edaravone Dexborneol [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing neuroprotection with edaravone dexborneol after thrombectomy in ischemic stroke with sufficient recanalization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Edaravone Dexborneol

Snippet

Sponsor: Hui-Sheng Chen | Conditions: Stroke, Endovascular Thrombectomy | Phase 2 | Status: COMPLETED